Fibronostics ^Company

Fibronostics is a healthcare technology company that specializes in the development of artificial intelligence-based noninvasive diagnostics. Their main goal is to transform non-invasive solutions for early disease intervention. Using a combination of broadly available biomarkers and neural network-based AI, Fibronostics provides noninvasive diagnostic accuracy equivalent to biopsy. Their flagship product, LIVERFASt™, helps determine the degree of fibrosis, activity, and steatosis in the liver of NAFLD patients from early stage to late stage disease. By enabling earlier diagnosis and intervention, Fibronostics aims to improve patient outcomes and optimize disease management.